6
Total deals
$1.7B
Total value
$837.5M
Avg deal
$1.4B
Largest
| # | Acquired | Date | Type | Status | Price | |
|---|---|---|---|---|---|---|
| 1 |
Escient Pharmaceuticals
Escient Pharmaceuticals is a privately-held biotechnology company focusing on th…
|
2024-04-23 | Acquisition | Complete | — | Deal → |
| 2 |
Villaris Therapeutics
Villaris Therapeutics is a preclinical-stage biopharmaceutical company.
|
2022-10-03 | Acquisition | Complete | $1.4B | Deal → |
| 3 |
A
ARIAD Pharmaceuticals - European operations
ARIAD Pharmaceuticals - European operations focuses on cancer.
|
2016-05-09 | Acquisition | Complete | $275.0M | Deal → |
| 4 |
M
Maxia Pharmaceuticals
Maxia Pharmaceuticals is a privately-held drug discovery and development company…
|
2003-02-18 | Acquisition | Complete | — | Deal → |
| 5 |
Proteome
A wholly-owned subsidiary of Incye Corporation.
|
2000-12-01 | Acquisition | Complete | — | Deal → |
| 6 |
S
Synteni
Synteni is a privately held microarray-based gene expression company.
|
1998-01-22 | Acquisition | Complete | — | Deal → |